Although CD4 memory help functions seem to directly influence PD-L1/PD-1 inhibitor effects on CD8 anti-tumor responses, the molecular mechanisms by which both populations interplay during PD-L1/PD-1 blockade therapy remain to be fully understood. The gene discussed is CD8A; the disease is neoplasm.